
Siemens Healthineers AG
SMMNY | OTC
$23.83
-$0.14 (-0.58%)
At close: Oct 30, 2026, 3:59 PM ET
$23.81
-$0.02 (-0.08%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Company Profile
Siemens Healthineers AG (SMMNY), operating through its various subsidiaries, is a global enterprise that provides a comprehensive suite of diagnostic and therapeutic medical products and services. These offerings are extended to healthcare professionals and institutions across numerous international markets, including Germany, the United States, the broader European continent, the CIS region, Africa, the Middle East, the Americas, the Asia Pacific region, Japan, and China. The company's business is structured across four primary divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment supplies cutting-edge systems such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray, molecular imaging, and ultrasound technologies. It also develops sophisticated software solutions designed to streamline the interpretation and structured reporting of diagnostic images from diverse modalities. The Diagnostics segment delivers in-vitro diagnostic products and associated services, catering to healthcare providers in both general and specialized laboratory settings, as well as point-of-care diagnostics. This division further offers workflow solutions to optimize laboratory operations and provides advanced informatics products. The Varian segment specializes in oncology solutions, featuring advanced technologies like microwave, cryoablation, and embolization. It also furnishes extensive clinical professional services and tailored support programs to assist oncology departments in hospitals and clinics with their cancer care operations. The Advanced Therapies segment focuses on developing products that facilitate image-guided, minimally invasive clinical procedures. These solutions are applied across various medical specialties, including cardiology, neurology, and oncology. Its portfolio includes angiography systems, mobile C-arms, and AI-powered clinical applications that enhance procedural precision. Beyond its core product lines, Siemens Healthineers AG offers a broad range of essential technical customer services. These include maintenance and repair, provision of spare parts, medical equipment performance management, training programs, clinical education, e-learning resources, planning and design assistance, financing options, asset management, and managed departmental services for laboratories and other healthcare facilities. The company also provides healthcare consulting, products, and additional services. Established in 1896, Siemens Healthineers AG maintains its corporate headquarters in Forchheim, Germany, and functions as a subsidiary of Siemens Aktiengesellschaft.
Key Executives
| Name | Position |
|---|---|
| Bernhard Montag | President, Chief Executive Officer & Chairman of Management Board |
| Jochen Schmitz | Chief Financial Officer & Member of Management Board |
| Astrid Kristine Ploss | Member of Supervisory Board, Head of Legal Advanced Therapies & Head of Legal Technology Excellence |
| Christian Klaussner | Executive Vice President of Finance |
| Darleen Caron | Chief Human Resources Officer, Labor Director & Member of Management Board |
| Elisabeth Staudinger | Member of Management Board |
| Jerry Wang | Head of China |
| Marc Koebernick | Head of Investor Relations |
| Matthias Kraemer | Head of Corporate Communications |
| Sharon J. Bracken | Head of Diagnostics |
Siemens Healthineers AG

| Country | Germany |
| IPO Date | May 14, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 74,000 |
| CEO | Bernhard Montag |
Contact Details
Siemensstr. 3 Forchheim,
BV 91301 Germany
Stock Details
| Ticker Symbol | SMMNY |
| Exchange | OTC |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | 82622J104 |
| ISIN Number | US82622J1043 |
| SIC Code | n/a |
Recent News
- 1 month ago / seekingalpha.comSiemens Healthineers AG (SMMNY) Discusses Foreign Exchange and Tariff Impacts on Q4 Revenue and Earnings Prepared Remarks Transcript
- 1 month ago / businesswire.comSun Nuclear Announces Validated Adaptive QA Solution in Support of New Radiotherapy System, Accela, by Siemens Healthineers
- 2 months ago / seekingalpha.comSiemens Healthineers: Successful Investment, Updating For H2 2026
- 3 months ago / seekingalpha.comSiemens Healthineers AG (SMMNY) Q3 2026 Earnings Call Transcript
- 3 months ago / wsj.comSiemens Healthineers Cuts Revenue Outlook on Diagnostics Weakness
- 3 months ago / reuters.comSiemens Healthineers cuts revenue forecast citing diagnostics weakness
- 4 months ago / seekingalpha.comSiemens Healthineers AG (SMMNY) Discusses Q3 Pre-Close Updates: Foreign Exchange and Tariff Impacts on Revenue and Earnings Prepared Remarks Transcript
Add to Watchlist
Select watchlists to add or remove SMMNY